Polynovo Ltd - Asset Resilience Ratio
Polynovo Ltd (PNV) has an Asset Resilience Ratio of 0.04% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how Polynovo Ltd's Asset Resilience Ratio has changed over time. Check Polynovo Ltd (PNV) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Polynovo Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PNV market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$50.00K | 0.04% |
| Total Liquid Assets | AU$50.00K | 0.04% |
Asset Resilience Insights
- Limited Liquidity: Polynovo Ltd maintains only 0.04% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Polynovo Ltd Industry Peers by Asset Resilience Ratio
Compare Polynovo Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Getein Biotech Inc
SHG:603387 |
Medical Devices | 29.77% |
|
Ningbo David Medical Device Co Ltd
SHE:300314 |
Medical Devices | 6.89% |
|
Vieworks Co. Ltd
KQ:100120 |
Medical Devices | 7.81% |
|
Somnomed Ltd
AU:SOM |
Medical Devices | 24.67% |
|
Dynamic Medical Technologies
TWO:4138 |
Medical Devices | 18.54% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
Annual Asset Resilience Ratio for Polynovo Ltd (2000–2025)
The table below shows the annual Asset Resilience Ratio data for Polynovo Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 5.46% | AU$6.96 Million ≈ $4.92 Million |
AU$127.41 Million ≈ $90.15 Million |
-16.88pp |
| 2024-06-30 | 22.34% | AU$24.29 Million ≈ $17.19 Million |
AU$108.72 Million ≈ $76.93 Million |
+22.29pp |
| 2023-06-30 | 0.05% | AU$50.00K ≈ $35.38K |
AU$92.62 Million ≈ $65.54 Million |
-0.09pp |
| 2022-06-30 | 0.14% | AU$50.00K ≈ $35.38K |
AU$34.97 Million ≈ $24.74 Million |
+0.01pp |
| 2021-06-30 | 0.13% | AU$50.00K ≈ $35.38K |
AU$38.34 Million ≈ $27.13 Million |
0.00pp |
| 2020-06-30 | 0.13% | AU$50.00K ≈ $35.38K |
AU$37.86 Million ≈ $26.79 Million |
-0.05pp |
| 2019-06-30 | 0.18% | AU$50.00K ≈ $35.38K |
AU$28.23 Million ≈ $19.97 Million |
-63.70pp |
| 2018-06-30 | 63.88% | AU$19.05 Million ≈ $13.48 Million |
AU$29.82 Million ≈ $21.10 Million |
+63.46pp |
| 2017-06-30 | 0.41% | AU$50.00K ≈ $35.38K |
AU$12.06 Million ≈ $8.53 Million |
+0.10pp |
| 2016-06-30 | 0.31% | AU$50.00K ≈ $35.38K |
AU$16.02 Million ≈ $11.34 Million |
-0.43pp |
| 2015-06-30 | 0.74% | AU$60.00K ≈ $42.45K |
AU$8.13 Million ≈ $5.75 Million |
+0.10pp |
| 2014-06-30 | 0.64% | AU$60.00K ≈ $42.45K |
AU$9.41 Million ≈ $6.66 Million |
-12.82pp |
| 2013-06-30 | 13.46% | AU$1.16 Million ≈ $820.77K |
AU$8.62 Million ≈ $6.10 Million |
-7.42pp |
| 2012-06-30 | 20.88% | AU$1.86 Million ≈ $1.32 Million |
AU$8.91 Million ≈ $6.30 Million |
-11.06pp |
| 2011-06-30 | 31.94% | AU$3.76 Million ≈ $2.66 Million |
AU$11.77 Million ≈ $8.33 Million |
+31.54pp |
| 2010-06-30 | 0.40% | AU$60.00K ≈ $42.45K |
AU$15.02 Million ≈ $10.63 Million |
-86.21pp |
| 2000-06-30 | 86.61% | AU$10.36 Million ≈ $7.33 Million |
AU$11.96 Million ≈ $8.46 Million |
-- |
About Polynovo Ltd
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more